liposomal cytarabine-daunorubicin

liposomal cytarabine-daunorubicin · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for liposomal cytarabine-daunorubicin, covering 2023-12-28 to 2023-12-28. Get the full timeline:

Most recent: Clinical Trial Update: A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia [Phase 3]

See pricing